Katheterablation bei paroxysmalem Vorhofflimmern – bereits vor Beginn einer medikamentösen antiarrhythmischen Therapie?

Abstract

Atrial fibrillation (AF) is the most common arrhythmia especially in elderly persons. Pulmonary vein isolation has become an accepted treatment option in symptomatic patients with paroxysmal and persistent atrial fibrillation after failed antiarrhythmic medication. Today two studies are available, which examined the first line pulmonary vein isolation in young patients with paroxysmal atrial fibrillation and no significant structural heart disease compared to antiarrhythmic medication and could show an advantage for the ablation strategy. Therefore in patients with paroxysmal atrial fibrillation and no significant structural heart disease pulmonary vein isolation can be recommended as first line therapy.

• Literatur

• 1 Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375
• 2 Camm AJ, Lip GYH, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. . European heart journal 2012; 33: 2719-2747
• 3 Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833
• 4 Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840
• 5 Vamos M, Erath JW, Hohnloser SH. Digoxin-associated mortality: a systematic review and meta-analysis of the literature. European Heart Journal 2015; 1993: 1-8
• 6 Bonanno C, Paccanaro M, La Vecchia L et al. Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials. Journal of cardiovascular medicine (Hagerstown, Md.) 2010; 11: 408-418
• 7 Deshmukh A, Patel NJ, Pant S et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: Analysis of 93 801 procedures. Circulation 2013; 128: 2104-2112
• 8 Luik A. Cryo-Ballon Ablation versus Open-irrigated RF Ablation bei Patienten mit paroxsysmalem Vorhofflimmern – Ergebnisse der prospectiven, randomisierten FreezeAF Studie. Clin Res Cardiol 2015; 104
• 9 Cosedis Nielsen J, Johannessen A, Raatikainen P et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. The New England journal of medicine 2012; 367: 1587-1595
• 10 Morillo C, Verma A, Kuck KH et al. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Lne Treatment of Symptomatic Atrial Fibrillation: (RAAFT 2): a Randomized Trial. Heart Rhythm 2012; 9: 1580